46 results
6-K
TAK
Takeda Pharmaceutical Co
30 Oct 23
Current report (foreign)
6:02am
improvement. The CONTACT-02 trial compared the combination therapy of CABOMETYX and atezolizumab, an anti-PD-L1 (Programmed Death-Ligand 1) humanized
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
to serious complications including death.7 There are approximately 20,000 to 25,000 deaths globally, mainly among children, due to the virus.8 Hospital
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
23 Jun 23
Current report (foreign)
6:13am
in the risk of death (hazard ratio [HR] 0.59; 95% confidence interval [CI]: 0.396 to 0.879), with an estimated OS rate (95% CI) of 93.9% (91.6, 95.5) at 6 years
6-K
TAK
Takeda Pharmaceutical Co
9 Jun 23
Current report (foreign)
6:03am
awards and PSU awards, upon the occurrence of certain events, including the employee’s death, instead of Company ADSs, cash in an amount equivalent
6-K
EX-99.1
6u3w7d3cu2
30 May 23
Current report (foreign)
6:11am
6-K
983tuoy oinlam4j111
8 Dec 22
Current report (foreign)
6:46am
6-K
EX-99.1
56x7cx h6yna
30 Nov 22
Current report (foreign)
6:28am
6-K
wrhzqq5 5gz4
4 Nov 22
Current report (foreign)
6:01am
6-K
7dzqaxpc ht
14 Oct 22
Current report (foreign)
7:36am
6-K
EX-99.1
utei912z85cl3o9
23 Aug 22
Current report (foreign)
6:13am
6-K
4f61q
4 Aug 22
Current report (foreign)
6:07am
S-8
EX-99.1
ivicmvm 2l
29 Jun 22
Registration of securities for employees
6:13am
6-K
r0lspc4g6hl0icmjy0
10 Jun 22
Current report (foreign)
6:00am
6-K
EX-99.1
tgtat5ek0 b7g7
31 May 22
Current report (foreign)
6:07am
6-K
t0lu0v25nnz8o90t4
10 Feb 22
Current report (foreign)
6:03am
6-K
3u1iq9cvrwlqwiqo
5 Nov 21
Current report (foreign)
6:02am
6-K
9gajbbtwjfgn8hnpjp
7 Sep 21
Current report (foreign)
6:02am
6-K
elywzfle157 w68u
8 Jul 21
Current report (foreign)
6:21am